
For the PDF version of the
Patient Brochure click here
(PDF 2.617 MB)

Tetracycline hydrochloride is encapsulated within a smaller capsule to create a barrier to avoid contact with bismuth subcitrate potassium
PYLERA® is an innovative 3-in-1 therapy, meaning it has three active ingredients in one capsule. You will need to take PYLERA® with the acid reducer omeprazole. Omeprazole is a proton pump inhibitor (PPI) that reduces the amount of acid produced in the stomach. You benefit by only needing to take two types of pills. Each capsule contains bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride, all of which act together to fight H. pylori. Acid suppression by the PPI in conjunction with the antibiotics, helps alleviate symptoms, heal the ulcer and eliminate H. pylori1. PYLERA® is generally well-tolerated and has a low risk of allergic reaction in most patients. H. pylori infection will not recur in over 90% of patients who complete their PYLERA® regimen as prescribed.1
Information on this website is not intended to replace the advice of your physician(s). Please consider what you learn here a starting point for a conversation with your physician. PYLERA® is a prescription drug; please ask your physician if PYLERA® is right for you.
Reference
1. Laine L, Hunt R, EI-Zimaity H, Nguyen B, Osato M, Spenard J. Bismuth based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eraditation of Helicobacter pylori in duodenal ulcer patients: A prospective, randomized, multicenter, North American trial. Am J Gastroenterol 2003; 98:562-567.